Literature DB >> 6724133

Protein synthesis in dorsal and ventral regions of Xenopus laevis embryos in relation to dorsal and ventral differentiation.

R C Smith, J Knowland.   

Abstract

Two-dimensional gel electrophoresis has been used to analyze protein synthesis in dorsal and ventral regions in embryonic stages of Xenopus laevis. Proteins specific either to dorsal or to ventral regions are synthesized for the first time at gastrulation, concomitant with morphological differentiation. The reliability of these proteins as markers of dorsal and ventral differentiation was tested by examining their synthesis in Uv-irradiated embryos, which have severely reduced capacity for dorsal development, reflected in reduced levels of the neuromuscular-specific enzyme acetylcholinesterase, but which continue to synthesize the great majority of proteins at normal rates. Synthesis of dorsal indicator proteins should be reduced or absent in these embryos, whereas ventral indicators should be synthesized at least to the same extent as in control embryos. Some of the putative dorsal and ventral indicators failed this test, but the majority were confirmed as reliable markers of dorsal and ventral differentiation, thus providing a connection between morphology and gene expression in the establishment of the dorsal-ventral axis in X. laevis.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6724133     DOI: 10.1016/0012-1606(84)90324-5

Source DB:  PubMed          Journal:  Dev Biol        ISSN: 0012-1606            Impact factor:   3.582


  2 in total

1.  Activation of chromosomal vitellogenin genes in Xenopus oocytes by pure estrogen receptor and independent activation of albumin genes.

Authors:  E A McKenzie; N A Cridland; J Knowland
Journal:  Mol Cell Biol       Date:  1990-12       Impact factor: 4.272

2.  Correlations between cell fate and the distribution of proteins that are synthesized before the midblastula transition in Xenopus.

Authors:  Steven L Klein; Mary Lou King
Journal:  Rouxs Arch Dev Biol       Date:  1988-08
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.